Enhancing distress tolerance to uplift motivation in recovery: Results from an open development trial.
Prachi Hemant BhuptaniAmanda BlockPaola Jiménez MuñozMariel S BelloSusan RamseyMegan RanneyKate CareyJosiah RichKirsten J LangdonPublished in: Digital health (2023)
Preliminary findings from this pilot suggest that the content and delivery method of this combined web- and text message-based personalized feedback intervention is perceived by patients as feasible and acceptable. Leveraging digital health platforms to augment buprenorphine has potential for high scalability and impact to reduce opioid use, increase adherence/retention to treatment, and prevent future incidence of overdose. Future work will evaluate the efficacy of the intervention in a randomized clinical trial design.
Keyphrases
- randomized controlled trial
- end stage renal disease
- study protocol
- mental health
- public health
- current status
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- clinical trial
- depressive symptoms
- peritoneal dialysis
- prognostic factors
- risk factors
- insulin resistance
- phase ii
- patient reported outcomes
- skeletal muscle
- smoking cessation
- placebo controlled